Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Katya Zelevinsky

Showing results (11-20 of 32) with videos related to

Pageof 4
Sort By:
JAMA Network Open|May 23, 2020
Assessment of Second-Generation Diabetes Medication Initiation Among Medicare Enrollees From 2007 to 2015Lauren G Gilstrap, Rachel A Blair, Haiden A Huskamp, et al.
Circulation. Cardiovascular Quality and Outcomes|December 16, 2010
Impact of independent data adjudication on hospital-specific estimates of risk-adjusted mortality following percutaneous coronary interventions in massachusettsKurt G Barringhaus, Katya Zelevinsky, Ann Lovett, et al.
The Annals of Thoracic Surgery|September 15, 2025
Improving Risk Adjustment in the Assessment of Congenital Heart Center Surgical QualitySharon-Lise Normand, Katya Zelevinsky, Larry Han, et al.
The Annals of Thoracic Surgery|October 23, 2025
Understanding Mortality After Congenital Heart Surgery: What Do Procedure-Specific Factors Add?Meena Nathan, Larry Han, Katya Zelevinsky, et al.
Bjpsych Open|August 8, 2024
Revisiting diabetes risk of olanzapine versus aripiprazole in serious mental illness careDenis Agniel, Sharon-Lise T Normand, John W Newcomer, et al.
Administration and Policy in Mental Health|May 19, 2021
Significance and Factors Associated with Antipsychotic Polypharmacy Utilization Among Publicly Insured US AdultsMarcela Horvitz-Lennon, Rita Volya, Katya Zelevinsky, et al.
Psychiatric Services (Washington, D.C.)|June 2, 2021
Factors Associated With Off-Label Utilization of Second-Generation Antipsychotics Among Publicly Insured AdultsMarcela Horvitz-Lennon, Rita Volya, Simon Hollands, et al.
Psychological Medicine|September 27, 2023
Antipsychotics and the risk of diabetes and death among adults with serious mental illnessesJason Poulos, Sharon-Lise T Normand, Katya Zelevinsky, et al.
JAMA Network Open|January 17, 2025
Race and Ethnicity and Diffusion of Telemedicine in Medicaid for Schizophrenia Care After Onset of the COVID-19 PandemicSharon-Lise Normand, Emily Leckman-Westin, Molly Finnerty, et al.
Community Mental Health Journal|June 13, 2023
Correction to: Healthcare Access for a Diverse Population with Schizophrenia Following the Onset of the COVID‑19 PandemicMarcela Horvitz-Lennon, Emily Leckman-Westin, Molly Finnerty, et al.
Pageof 4

Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
JAMA Network Open|May 23, 2020
Assessment of Second-Generation Diabetes Medication Initiation Among Medicare Enrollees From 2007 to 2015Lauren G Gilstrap, Rachel A Blair, Haiden A Huskamp, et al.
Circulation. Cardiovascular Quality and Outcomes|December 16, 2010
Impact of independent data adjudication on hospital-specific estimates of risk-adjusted mortality following percutaneous coronary interventions in massachusettsKurt G Barringhaus, Katya Zelevinsky, Ann Lovett, et al.
The Annals of Thoracic Surgery|September 15, 2025
Improving Risk Adjustment in the Assessment of Congenital Heart Center Surgical QualitySharon-Lise Normand, Katya Zelevinsky, Larry Han, et al.
The Annals of Thoracic Surgery|October 23, 2025
Understanding Mortality After Congenital Heart Surgery: What Do Procedure-Specific Factors Add?Meena Nathan, Larry Han, Katya Zelevinsky, et al.
Bjpsych Open|August 8, 2024
Revisiting diabetes risk of olanzapine versus aripiprazole in serious mental illness careDenis Agniel, Sharon-Lise T Normand, John W Newcomer, et al.
Administration and Policy in Mental Health|May 19, 2021
Significance and Factors Associated with Antipsychotic Polypharmacy Utilization Among Publicly Insured US AdultsMarcela Horvitz-Lennon, Rita Volya, Katya Zelevinsky, et al.
Psychiatric Services (Washington, D.C.)|June 2, 2021
Factors Associated With Off-Label Utilization of Second-Generation Antipsychotics Among Publicly Insured AdultsMarcela Horvitz-Lennon, Rita Volya, Simon Hollands, et al.
Psychological Medicine|September 27, 2023
Antipsychotics and the risk of diabetes and death among adults with serious mental illnessesJason Poulos, Sharon-Lise T Normand, Katya Zelevinsky, et al.
JAMA Network Open|January 17, 2025
Race and Ethnicity and Diffusion of Telemedicine in Medicaid for Schizophrenia Care After Onset of the COVID-19 PandemicSharon-Lise Normand, Emily Leckman-Westin, Molly Finnerty, et al.
Community Mental Health Journal|June 13, 2023
Correction to: Healthcare Access for a Diverse Population with Schizophrenia Following the Onset of the COVID‑19 PandemicMarcela Horvitz-Lennon, Emily Leckman-Westin, Molly Finnerty, et al.
Pageof 4